358 related articles for article (PubMed ID: 29624602)
1. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
[TBL] [Abstract][Full Text] [Related]
2. MK-8719, a Novel and Selective
Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
[TBL] [Abstract][Full Text] [Related]
3. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
4. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
[TBL] [Abstract][Full Text] [Related]
5. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
[TBL] [Abstract][Full Text] [Related]
6. Increasing O-GlcNAcylation Attenuates tau Hyperphosphorylation and Behavioral Impairment in rTg4510 Tauopathy Mice.
Rostgaard N; Jul PH; Garmer M; Volbracht C
J Integr Neurosci; 2023 Sep; 22(5):135. PubMed ID: 37735138
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice.
Hastings NB; Wang X; Song L; Butts BD; Grotz D; Hargreaves R; Fred Hess J; Hong KK; Huang CR; Hyde L; Laverty M; Lee J; Levitan D; Lu SX; Maguire M; Mahadomrongkul V; McEachern EJ; Ouyang X; Rosahl TW; Selnick H; Stanton M; Terracina G; Vocadlo DJ; Wang G; Duffy JL; Parker EM; Zhang L
Mol Neurodegener; 2017 May; 12(1):39. PubMed ID: 28521765
[TBL] [Abstract][Full Text] [Related]
8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
9. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
10. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
[TBL] [Abstract][Full Text] [Related]
11. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
12. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
Yue M; Hanna A; Wilson J; Roder H; Janus C
Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent impairment of memory and neurofibrillary tangle formation and clearance in a mouse model of tauopathy.
Kubota T; Kirino Y
Brain Res; 2021 Aug; 1765():147496. PubMed ID: 33894222
[TBL] [Abstract][Full Text] [Related]
14. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
15. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
[TBL] [Abstract][Full Text] [Related]
16. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
17. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
[TBL] [Abstract][Full Text] [Related]
18. Tau reduction in the presence of amyloid-β prevents tau pathology and neuronal death in vivo.
DeVos SL; Corjuc BT; Commins C; Dujardin S; Bannon RN; Corjuc D; Moore BD; Bennett RE; Jorfi M; Gonzales JA; Dooley PM; Roe AD; Pitstick R; Irimia D; Frosch MP; Carlson GA; Hyman BT
Brain; 2018 Jul; 141(7):2194-2212. PubMed ID: 29733334
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
20. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy.
Spires-Jones TL; Friedman T; Pitstick R; Polydoro M; Roe A; Carlson GA; Hyman BT
Neurosci Lett; 2014 Mar; 562():63-8. PubMed ID: 24462887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
